-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 VrfaN/2l8hbHIOZsRHC5MsfwhNrmGRojAwfADMy+MjU3hoaH8pGQQG6m5LwWnkEK
 MSpcvkgijZjMeKcAZaBDHA==

<SEC-DOCUMENT>0001200148-03-000002.txt : 20030922
<SEC-HEADER>0001200148-03-000002.hdr.sgml : 20030922
<ACCEPTANCE-DATETIME>20030922184410
ACCESSION NUMBER:		0001200148-03-000002
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20030918
FILED AS OF DATE:		20030922

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOJECT MEDICAL TECHNOLOGIES INC
		CENTRAL INDEX KEY:			0000810084
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				931099680
		STATE OF INCORPORATION:			OR
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		7620 S W BRIDGEPORT RD
		CITY:			PORTLAND
		STATE:			OR
		ZIP:			97224
		BUSINESS PHONE:		5036397221

	MAIL ADDRESS:	
		STREET 1:		7620 S W BRIDGEPORT ROAD
		CITY:			PORTLAND
		STATE:			OR
		ZIP:			97224

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOJECT MEDICAL SYSTEMS LTD
		DATE OF NAME CHANGE:	19920703

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			RUEDY JOHN
		CENTRAL INDEX KEY:			0001200148

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-15360
		FILM NUMBER:		03904944

	BUSINESS ADDRESS:	
		STREET 1:		211 SOMERVILLE RD 202N
		CITY:			BEDMINSTER
		STATE:			NJ
		ZIP:			07921
		BUSINESS PHONE:		9087192244

	MAIL ADDRESS:	
		STREET 1:		1210 CROMWELL ROAD
		CITY:			HALIFAX NOVA SCOTIA
		STATE:			A5
		ZIP:			B3H4L2
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>rue10.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>
    <schemaVersion>X0201</schemaVersion>

    <documentType>4</documentType>
	<periodOfReport>2003-09-18</periodOfReport>
	<notSubjectToSection16>0</notSubjectToSection16>
    <issuer>
        <issuerCik>0000810084</issuerCik>
        <issuerName>BIOJECT MEDICAL TECHNOLOGIES INC</issuerName>
        <issuerTradingSymbol>BJCT</issuerTradingSymbol>
	</issuer>
	<reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001200148</rptOwnerCik>
            <rptOwnerName>RUEDY JOHN</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>211 SOMERVILLE ROAD</rptOwnerStreet1>
            <rptOwnerStreet2>ROUTE 202 N</rptOwnerStreet2>
            <rptOwnerCity>BEDMINSTER</rptOwnerCity>
            <rptOwnerState>NJ</rptOwnerState>
            <rptOwnerZipCode>07921</rptOwnerZipCode>
            <rptOwnerStateDescription>NOVA SCOTIA, CANADA</rptOwnerStateDescription>
        </reportingOwnerAddress>
            <reportingOwnerRelationship>
			<isDirector>1</isDirector>
			<isOfficer>0</isOfficer>
			<isTenPercentOwner>0</isTenPercentOwner>
			<isOther>1</isOther>
			<otherText>INSIDER</otherText>
		</reportingOwnerRelationship>
	</reportingOwner>
	<derivativeTable>
		<derivativeTransaction>
			<securityTitle>
				<value>Stock Option (Right to Buy)</value>
			</securityTitle>
			<conversionOrExercisePrice>
				<value>4.03</value>
			</conversionOrExercisePrice>
			<transactionDate>
				<value>2003-09-18</value>
			</transactionDate>
			<deemedExecutionDate>
				<value>2003-09-18</value>
			</deemedExecutionDate>
			<transactionCoding>
				<transactionFormType>4</transactionFormType>
				<transactionCode>A</transactionCode>
				<equitySwapInvolved>0</equitySwapInvolved>
			</transactionCoding>
			<transactionAmounts>
				<transactionShares>
					<value>1000</value>
				</transactionShares>
				<transactionPricePerShare>
					<value>0</value>
				</transactionPricePerShare>
				<transactionAcquiredDisposedCode>
					<value>A</value>
				</transactionAcquiredDisposedCode>
			</transactionAmounts>
			<exerciseDate>
				<value>2004-03-18</value>
				<footnoteId id="F1"/>
			</exerciseDate>
			<expirationDate>
				<value>2011-09-17</value>
			</expirationDate>
			<underlyingSecurity>
				<underlyingSecurityTitle>
					<value>Common Stock</value>
				</underlyingSecurityTitle>
				<underlyingSecurityShares>
					<value>1000.00</value>
				</underlyingSecurityShares>
			</underlyingSecurity>
			<postTransactionAmounts>
				<sharesOwnedFollowingTransaction>
					<value>1000.00</value>
				</sharesOwnedFollowingTransaction>
			</postTransactionAmounts>
			<ownershipNature>
				<directOrIndirectOwnership>
					<value>D</value>
				</directOrIndirectOwnership>
				<natureOfOwnership>
					<value/>
				</natureOfOwnership>
			</ownershipNature>
		</derivativeTransaction>
	</derivativeTable>
	<footnotes>
		<footnote id="F1">50% six months from date of grant, 50% one year from date of grant</footnote>
	</footnotes>
	<remarks>
	</remarks>
	<ownerSignature>
		<signatureName>By: John Gandolfo, Attorney-in-fact</signatureName>
		<signatureDate>2003-09-15</signatureDate>
	</ownerSignature>
</ownershipDocument>

</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----